tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Amwell lowers top-end of FY25 revenue view to $245M-$248M from $245M-$250M

FY25 revenue consensus $247.79M. Narrows FY25 adjusted EBITDA guidance to (45M)-(42M) from (50M)-(45M). Reaffirms AMG visits view 1.3M-1.35M. The company noted their FY25 guidance revision reflects the previously announced divestiture of Amwell (AMWL) Psychiatric Care.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1